Also, glutaminase (GLS1), the key enzyme converting glutamine to glutamate, has shown higher expression levels in T3/T4 tumors, and in tumors with higher Gleason scores [66–68]; a behavior suggesting an association of elevated expression with PC progression. The gene discussed is GLS; the disease is pachyonychia congenita.